
|Articles|April 22, 2008
Colesevelam now included in ACE/AACE guide as combination therapy for glycemic control
Bile sequestrant colesevelam now included in endocrinologist groups' diabetes guide.
Advertisement
The American College of Endocrinologists (ACE) and the American Association of Endocrinologists (AACE) have included colesevelam (Welchol, Daiichi Sankyo), a bile acid sequestrant, as an option for treating patients with Type 2 diabetes in their Road Maps to Achieve Glycemic Control in
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Embedded Pharmacists Are Vital Yet Underutilized in Diabetes Care
2
Executive Order Calls for Realignment of Childhood Vaccines
3
The Prodigious PBM Pivot: How Supply Chain Entities Will Move Forward After CAA 2026
4
Heat and Older Adults: What Pharmacists Need to Know
5





























































